Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

C4 Therapeutics completes $73.5mm Series A round

Executive Summary

C4 Therapeutics Inc., which is targeting disease-causing proteins, raised $73.5mm in Series A financing from 55 investors, led by angel backers including Cobro Ventures (run by C4's chairman Marc Cohen), plus Cormorant Asset Management, the Kraft Group, EG Capital Group, Roche, and Novartis AG.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies